Archives
-
SAR405: Vps34 Precision at the Autophagy–Genome Interface
2026-09-29
SAR405 is a selective ATP-competitive Vps34 inhibitor that connects precise PtdIns3P pathway perturbation with questions in autophagy, vesicle trafficking, lysosome biology, and DNA mismatch repair. This thought-leadership guide shows how translational researchers can use SAR405 to move beyond standard autophagy readouts and test emerging links between Vps34 signaling and genome maintenance.
-
Nonivamide (Capsaicin Analog) Assay Guide
2026-09-29
This scenario-based guide explains how Nonivamide (Capsaicin Analog), SKU A3278, can support more interpretable cell viability, proliferation, and apoptosis experiments. It covers solvent control, stock preparation, TRPV1 biology, assay optimization, and evidence-based product selection for cancer research workflows.
-
SW033291: Reliable 15-PGDH Assay Workflows
2026-09-28
Learn how SW033291 (SKU A8709) can anchor reproducible 15-PGDH inhibition studies across PGE2, hematopoietic, and tissue-repair assays. This scenario-driven guide connects biochemical potency, cell-based controls, formulation practice, and recent muscle-regeneration evidence to practical laboratory decisions.
-
Mecamylamine Hydrochloride: Assay Design Guide
2026-09-28
A practical guide to using Mecamylamine hydrochloride (SKU B7205) as a nicotinic receptor probe in cell-based and neuropsychiatric research. It covers assay controls, formulation, interpretation limits, and how to distinguish receptor-mediated effects from cytotoxicity.
-
SW033291 and Muscle Repair During Weight Loss
2026-09-27
SW033291 is a potent 15-PGDH inhibitor for probing prostaglandin E2 elevation and regenerative signaling. This article examines how recent muscle-repair findings during semaglutide treatment change the way researchers should measure muscle quality, target engagement, and functional recovery.
-
Hypoxia Duration Drives Urothelial Inflammation
2026-09-26
Hudson and colleagues show that brief and prolonged enzyme-induced hypoxia produce different responses in rat urothelial cells: early hypoxic signaling occurs without a measurable caspase-1 response, while longer exposure increases caspase-1 activity. Antioxidant and verapamil interventions support a ROS-associated TXNIP/NLRP3 interpretation, while leaving important questions about pathway specificity and translation to obstructed bladder tissue.
-
L-Threonine: Metabolic Workflows and Assay Design
2026-09-25
Use L-Threonine to create controlled nutrient-availability experiments for cell culture optimization and metabolic profiling—not as an ALP reagent. Pair that biological workflow with a separate, metal-free carbon-dot assay when ALP activity is the analytical question, keeping the two experiments distinct to limit confounding.
-
Hexamethonium Bromide and Autonomic BP Control
2026-09-25
Hexamethonium Bromide can help researchers test how autonomic ganglionic transmission contributes to blood pressure regulation. This article interprets sex-dependent angiotensin II findings as an experimental design problem, clarifying what ganglionic blockade can—and cannot—establish.
-
O-propargyl-puromycin (OPP) for B-Cell Translation
2026-09-24
Use O-propargyl-puromycin (OPP) to measure nascent protein production at the single-cell level and test how mitochondrial dysfunction may affect B-cell translation. This practical workflow connects the Pcbp1–Fdxr findings to an adaptable click-chemistry assay, with controls and troubleshooting guidance for interpreting results.
-
Ferroptosis Signature and Atorvastatin in HCC
2026-09-24
A 2025 study combined TCGA-based analysis of ferroptosis-related genes with experimental testing to develop a four-gene prognostic signature for hepatocellular carcinoma (HCC) and nominate Atorvastatin as a candidate treatment. The authors report that Atorvastatin induced ferroptosis and reduced HCC cell growth and migration in preclinical models, findings that warrant further validation rather than direct clinical extrapolation.
-
Tetraethylammonium Chloride: Research Workflows
2026-09-23
Use TEAC to test whether potassium-channel pore blockade contributes to a measured current or tissue response—not as a channel-subtype-specific probe. This workflow pairs practical dose-finding and controls with the key distinction between broad K⁺-channel experiments and the β-cell findings in the reference study.
-
Exemestane Workflow for Aromatase Research
2026-09-23
Build reproducible aromatase assays with Exemestane by combining concentration-response testing, time-dependent inhibition, and washout experiments. The workflow connects biochemical cytochrome P450 aromatase inhibition with cellular estrogen measurements while distinguishing enzyme blockade from receptor-level endocrine effects.
-
FLAG tag Peptide: Assay Design for Motor Proteins
2026-09-22
Learn how the FLAG tag Peptide (DYKDDDDK) can support modular recombinant protein detection, affinity recovery, and mechanistic kinesin assays. This guide connects peptide chemistry with recent BicD–MAP7 findings to improve experimental design rather than simply repeat purification instructions.
-
HMGB1 Proteomics for Early Diabetic Nephropathy
2026-09-22
The reference study combines quantitative serum proteomics with Mfuzz clustering, weighted gene co-expression network analysis, and experimental validation to identify biomarkers that track diabetic nephropathy progression. HMGB1 was prioritized as a candidate for early monitoring, although prospective clinical validation is still required before it can support routine diagnosis.
-
From IFN-I Repression to Translational Strategy
2026-09-21
A mechanistic analysis of how RUNX2–NCOR1–HDAC3 repression limits interferon signaling and immune checkpoint blockade in osteosarcoma, with a disciplined framework for evaluating Repaglinide as an exploratory metabolic-context comparator.